RA
Etanercept has demonstrated excellent safety and efficacy       in large scale, randomised, double blind, placebo controlled trials of patients       with RA and JRA who are refractory to other disease modifying anti-rheumatic       drugs.
Etanercept has demonstrated excellent safety and efficacy       in large scale, randomised, double blind, placebo controlled trials of  @OBJECT$         @PREDICAT$   @SUBJECT$  and JRA who are refractory to other disease modifying anti-rheumatic       drugs.